289 related articles for article (PubMed ID: 16757126)
21. Inherited prothrombotic risk factors in children with stroke, transient ischemic attack, or migraine.
Herak DC; Antolic MR; Krleza JL; Pavic M; Dodig S; Duranovic V; Brkic AB; Zadro R
Pediatrics; 2009 Apr; 123(4):e653-60. PubMed ID: 19336355
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
23. Feline factor XII (Hageman) deficiency.
Green RA; White F
Am J Vet Res; 1977 Jun; 38(6):893-5. PubMed ID: 879587
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between the central renin-angiotensin system, stress and hypertension].
Dumont EC; Drolet G
Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1111-3. PubMed ID: 10486675
[TBL] [Abstract][Full Text] [Related]
25. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
Herold R; Straub PW
J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
[No Abstract] [Full Text] [Related]
26. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
27. [Problems in atherosclerosis, hypertension, myocardial infarct and thrombosis in light of the theory of the functional role of the anticoagulation system].
Kalishevskaia TM
Patol Fiziol Eksp Ter; 1982; (2):82-6. PubMed ID: 6211649
[No Abstract] [Full Text] [Related]
28. Is atherosclerosis a neurogenic phenomenon?
Marwah RS; Doux JD; Lee PY; Yun AJ
Med Hypotheses; 2007; 69(4):884-7. PubMed ID: 17400398
[TBL] [Abstract][Full Text] [Related]
29. Platelet aggregometry in Hageman-deficients and in aspirin treated normal subjects.
Sarji KE; Iatridis PG; Rodman NF; Ferguson JH
Res Commun Chem Pathol Pharmacol; 1972 Jan; 3(1):177-88. PubMed ID: 5030704
[No Abstract] [Full Text] [Related]
30. Hyperresponsiveness of platelets in ischemic stroke.
Fateh-Moghadam S; Htun P; Tomandl B; Sander D; Stellos K; Geisler T; Langer H; Walton K; Handschu R; Garlichs C; Daniel WG; Gawaz M
Thromb Haemost; 2007 Jun; 97(6):974-8. PubMed ID: 17549300
[TBL] [Abstract][Full Text] [Related]
31. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
Eggers AE
Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938
[TBL] [Abstract][Full Text] [Related]
32. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
[TBL] [Abstract][Full Text] [Related]
33. Coagulation on endothelial cells: the underexposed part of Virchow's Triad.
Geenen IL; Post MJ; Molin DG; Schurink GW; Maessen JG; van Oerle R; ten Cate H; Spronk HM
Thromb Haemost; 2012 Nov; 108(5):863-71. PubMed ID: 22955519
[TBL] [Abstract][Full Text] [Related]
34. Thrombin and protease-activated receptors (PARs) in atherothrombosis.
Martorell L; Martínez-González J; Rodríguez C; Gentile M; Calvayrac O; Badimon L
Thromb Haemost; 2008 Feb; 99(2):305-15. PubMed ID: 18278179
[TBL] [Abstract][Full Text] [Related]
35. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
Gudmundsdóttir IJ; Lang NN; Boon NA; Ludlam CA; Webb DJ; Fox KA; Newby DE
J Am Coll Cardiol; 2008 May; 51(18):1749-56. PubMed ID: 18452780
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
Koenig JM; Chahine A; Ratnoff OD
J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
[TBL] [Abstract][Full Text] [Related]
37. Platelet hyperfunction as risk factor for chronic and acute coronary events.
Rao GH
Toxicol Mech Methods; 2005; 15(6):425-31. PubMed ID: 20021066
[TBL] [Abstract][Full Text] [Related]
38. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
39. Human urotensin II as a link between hypertension and coronary artery disease.
Watanabe T; Kanome T; Miyazaki A; Katagiri T
Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
